Skip to main content

Table 1 Demographic and clinical data of patients at baseline

From: Trazodone plus pregabalin combination in the treatment of fibromyalgia: a two-phase, 24-week, open-label uncontrolled study

 

(N = 41)

Sex (female/male)

39/2

Age (years)

(22-63)

(range and mean ± s.d.)

48 ± 10

Illness duration from diagnosis (years)

(1-19)

(range and mean ± s.d.)

46 ± 4.1

Most frequent comorbidities [N (%)]:

 

Temporomandibular dysfunction

30 (73)

Migraine

19 (46.3)

Irritable bowel syndrome

13 (32)

Chronic fatigue syndrome

7 (17.9)

Thyroid disease

7 (17.9)

Rheumathoid arthritis

9 (23.1)

Previous pharmacological treatments [N (%)]:

 

Paracetamol

22 (53.6)

NSAIDs

27 (65.8)

Tramadol

12 (29.3)

Benzodiazepines

25 (60.9)

Antidepressants

19 (46.3)

Anticonvulsants:

3 (7.3)

pregabalin/gabapentin

1 (2.4)

Non-pharmacological therapies [N (%)]

 

Tai Chi

2 (4.9)

Swimming pool

2 (4.9)

Ozone therapy

1 (2.4)

Yoga

1 (2.4)

Physiotherapy

1 (2.4